LabGenius

LabGenius is the first biopharmaceutical company developing next generation protein therapeutics using a machine learning-driven evolution engine (EVA) ™.

Our protein engineering platform integrates several bleeding edge technologies from the fields of machine learning, synthetic biology, and robotics. We use advanced deep-learning neural networks to explore protein fitness landscapes and improve multiple drug properties simultaneously.

We are a London-based, privately-owned company, backed by top-tier venture capital funds.

Company Type
Twitter Account
@labgeni_us
News Page URL
Click here